tiprankstipranks
TipRanksTop Financial ExpertsInsidersMark Jeffrey DeLong

Mark Jeffrey DeLong Insider Profile

4 Followers
Mark Jeffrey DeLong, Chief Business & Strat Officer at Apellis Pharmaceuticals, holds 0.00 shares in Apellis Pharmaceuticals (Ticker: APLS).
See the Hottest Stocks Based on Insider Trading >
tipranks
Mark Jeffrey DeLong

Mark Jeffrey DeLong
Apellis Pharmaceuticals (APLS)
Chief Business & Strat Officer

Ranked #4,318 out of 108,921 Corporate Insiders

Profitable Transactions

92%
12 out of 13 Profitable Transactions

Average Return

+29.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

Mark Jeffrey DeLong does not currently own shares as a corporate insider.
A breakdown of Mark Jeffrey DeLong's holdings
See the Top Stocks by Insiders

Insider Roles

Mark Jeffrey DeLong does not currently hold a role as a corporate insider.
Roles that Mark Jeffrey DeLong holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Apellis Pharmaceuticals
(APLS)
Rating:Informative Sell
Date:Feb 13, 2024 - Feb 13, 2025
Return:+58.50%
The most profitable trade made by Mark Jeffrey DeLong
See the Latest Stocks Traded by Insiders

Mark Jeffrey DeLong's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
APLS
Apellis Pharmaceuticals
May 14, 2026
―
Uninformative Buy
―
$0.00
APLS
is no longer traded
Success Rate for
APLS
12 out of 13 profitable transactions on
APLS
92%
Average Return for
APLS
Average return per transaction on
APLS
+29.52%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 27, 2021
Uninformative Buy
$0.00
882
$0.00
―
Jan 25, 2022
Uninformative Buy
$0.00
10,592
$0.00
―
Feb 14, 2022
Uninformative Buy
$0.00
4,901
$0.00
―
Jan 17, 2023
Uninformative Buy
$0.00
19,634
$0.00
―
Feb 22, 2023
Uninformative Buy
$0.00
5,280
$0.00
―
List of latest transactions for each holding click on a transaction to see Mark Jeffrey DeLong's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Mark Jeffrey DeLong insider profile FAQ

What is the percentage of profitable transactions made by Mark Jeffrey DeLong?
The percentage of profitable transactions made by Mark Jeffrey DeLong is 92%.
    What is the average return per transaction made by Mark Jeffrey DeLong?
    The average return per transaction made by Mark Jeffrey DeLong is 29.50%.
      What stocks does Mark Jeffrey DeLong hold?
      Mark Jeffrey DeLong holds: APLS stocks.
        What was Mark Jeffrey DeLong’s latest transaction?
        Mark Jeffrey DeLong latest transaction was an Uninformative Buy of ―.
          What was Mark Jeffrey DeLong's most profitable transaction?
          Mark Jeffrey DeLong’s most profitable transaction was an Informative Sell of APLS stock on February 13, 2024. The return on the trade was 58.50%.
            What is Mark Jeffrey DeLong's role in Apellis Pharmaceuticals?
            Mark Jeffrey DeLong's role in Apellis Pharmaceuticals is Chief Business & Strat Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.